SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.190-1.2%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: donpat12/11/2014 9:27:35 AM
  Read Replies (1) of 12873
 
Re: Reports

EUGENE SEYMOUR
8:33 AM (45 minutes ago)

to me

That's up to BASI

Sent from my iPhone

Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

On Dec 11, 2014, at 7:04 AM, I wrote:

Gene;

The question:

Could NNVC release the full report on the website with the letter head of the reporting organization.

On Thu, Dec 11, 2014 at 1:21 AM, EUGENE SEYMOUR< eugeneseymourmd@mac.com> wrote:

He's asking about the toxicology results

Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
A New York Stock Exchange Company

Sent from my iPad

On Dec 10, 2014, at 8:12 PM, I wrote:

Gene;

I'm not sure what this is all about but I'm sure you know:

NNVC posts a synopsis of reports they have received. Could NNVC release the full report on the website with the letter head of the reporting organization. Me would you ask please.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext